20040205
 Barr's Profit Falls As Charge Weighs On Revenue Surge   By Abboud, Leila, The Wall Street Journal,  Feb 6, 2004  Barr's strategy includes a major push in women's health products. Investors are closely watching the progress of heavily marketed Barr's Seasonale, a new kind of birth-control pill that limits menstrual cycles to four a year.  Barr also faces new competition in generic oral contraceptives, products that have helped drive the company's profits. Teva Pharmaceutical Industries Ltd. is jockeying for a bigger share of that market.   
